In Vitro Diagnostics Quality Control Market overview:
The In Vitro Diagnostics Quality Control Market type segment is categorized into quality control products, data management solutions, and quality assurance services. Quality control products are dominating the type segment in the in vitro diagnostics quality control market. By In Vitro Diagnostics Quality Control Market Application, the segment includes immunochemistry, hematology, molecular diagnostics, coagulation/hemostasis, and others.
The In Vitro Diagnostics Quality Control Market report includes a regional analysis and country analysis with the latest trends, along with the major key players including Biodesix, Adaptive Biotechnologies, Siemens Healthcare GmbH F. HOFFMANN-LA ROCHE LTD., QIAGEN, Illumina, Inc., Eurofins Scientific, Biotheranostics, Rosetta Genomics Ltd., Guardant Health.
In a recent research report by Reports Insight Consulting Pvt. Ltd,the In Vitro Diagnostics Quality Control (LDT) Market is expected to surpass USD 2.27 Billion by the year 2028, from USD 1.60 Billion in 2021.
In Vitro Diagnostics Quality Control Marketis projected to develop at a critical speed arriving at a CAGR of approximately 5.1%, over the conjecture time of 2022-2028, in spite of an extensive fall in Service Operator deals during the underlying period of pandemic spread and lockdown limitations forced universally.
The molecular diagnostics segment is expected to grab contributable market share in the year 2022. The factors supporting the growth of the market are the launch of advanced technologies such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), which boosted the demand for the molecular diagnostics market.
In the regional segment, Asia Pacific is projected to be the potential segment in the in vitro diagnostics quality control market. The factors expanding the growth of the market are the rising number of product manufacturing companies in the region. Further, the existence of regulatory authorities such as the Pharmaceuticals and Medical Devices Evaluation Agency (PMDA), the Ministry of Agriculture and Fisheries and Food, and the Ministry of Health, Labor and Welfare (MHLW) is expected to support the growth of the regional market.
The study is consolidated into major segments and further into sub-segments, such as by Type (Clinical Biochemistry, Molecular Diagnostics, Immunology, Critical Care, Microbiology, Haematology, Others), the Application (Hospitals laboratories, Specialty Diagnostic Centers, Clinical Research organizations, Academic Institutes, Others), to forecast the By size by In Vitro Diagnostics Quality Control Market value; also includes industry analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.